3,373 Shares in Integer Holdings Co. (NYSE:ITGR) Acquired by Algert Global LLC

Algert Global LLC acquired a new stake in Integer Holdings Co. (NYSE:ITGR) during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 3,373 shares of the medical equipment provider’s stock, valued at approximately $391,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its holdings in shares of Integer by 0.6% during the first quarter. Vanguard Group Inc. now owns 3,826,088 shares of the medical equipment provider’s stock worth $446,428,000 after acquiring an additional 23,382 shares in the last quarter. Earnest Partners LLC raised its stake in shares of Integer by 3.2% during the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock worth $139,911,000 after purchasing an additional 37,340 shares in the last quarter. Congress Asset Management Co. MA lifted its holdings in shares of Integer by 7.5% during the 1st quarter. Congress Asset Management Co. MA now owns 453,260 shares of the medical equipment provider’s stock valued at $52,886,000 after buying an additional 31,736 shares during the last quarter. Driehaus Capital Management LLC grew its stake in shares of Integer by 62.5% in the 2nd quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock valued at $40,880,000 after buying an additional 135,750 shares in the last quarter. Finally, Tributary Capital Management LLC raised its position in Integer by 0.3% during the second quarter. Tributary Capital Management LLC now owns 286,449 shares of the medical equipment provider’s stock valued at $33,168,000 after acquiring an additional 772 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Stock Performance

Shares of NYSE ITGR opened at $128.67 on Tuesday. Integer Holdings Co. has a one year low of $69.40 and a one year high of $131.87. The company has a current ratio of 3.29, a quick ratio of 1.96 and a debt-to-equity ratio of 0.73. The business has a fifty day simple moving average of $123.88 and a 200 day simple moving average of $119.61. The firm has a market capitalization of $4.31 billion, a price-to-earnings ratio of 44.52, a PEG ratio of 1.87 and a beta of 1.08.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.06. Integer had a net margin of 6.31% and a return on equity of 11.48%. The business had revenue of $436.20 million for the quarter, compared to analyst estimates of $437.00 million. During the same period in the previous year, the business earned $1.14 EPS. The firm’s revenue was up 9.0% on a year-over-year basis. Sell-side analysts expect that Integer Holdings Co. will post 5.31 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on ITGR shares. Truist Financial raised their price target on shares of Integer from $137.00 to $145.00 and gave the company a “buy” rating in a report on Tuesday, October 1st. Oppenheimer assumed coverage on Integer in a research report on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 price target for the company. Bank of America raised their price objective on Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research note on Tuesday, October 1st. Citigroup upped their target price on Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 1st. Finally, Benchmark reissued a “buy” rating and issued a $130.00 price target on shares of Integer in a research report on Wednesday, October 2nd. One research analyst has rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $137.29.

Insider Buying and Selling

In other Integer news, Director Jean M. Hobby sold 11,960 shares of the company’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total value of $1,431,133.60. Following the sale, the director now directly owns 2,280 shares in the company, valued at $272,824.80. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 2.00% of the stock is owned by corporate insiders.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.